Optimising Protection for Pregnant Women and Infants With Maternal Vaccination
Phase of Trial: Phase IV
Latest Information Update: 26 Jul 2018
Price : $35 *
At a glance
- Drugs DTaP vaccine (Primary) ; Influenza virus vaccine (Primary)
- Indications Influenza virus infections; Pertussis
- Focus Pharmacodynamics
- Acronyms OPTIWIN
- 31 Aug 2018 Biomarkers information updated
- 26 Jul 2018 Last checked against the ClinicalTrials.gov record.
- 18 Jul 2018 Status changed from not yet recruiting to recruiting.